EVALECGcardio Study
Launched by THE LEEDS TEACHING HOSPITALS NHS TRUST · Jul 8, 2020
Trial Information
Current as of May 10, 2025
Unknown status
Keywords
ClinConnect Summary
The aim of analysis is to determine if the handheld 6 lead ECG can be used as a simple screener to identify patients who do not need a 12 lead ECG.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Anyone attending cardiology outpatients or the ward who has had a recent ECG (within 6 hours)
- Exclusion Criteria:
- • Patients who do not consent to the study
About The Leeds Teaching Hospitals Nhs Trust
The Leeds Teaching Hospitals NHS Trust is a prominent healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality patient care, innovative research, and advanced medical education. As a leading clinical trial sponsor, the Trust plays a pivotal role in facilitating cutting-edge research initiatives that aim to improve health outcomes and advance medical knowledge. With a multidisciplinary team of experts and access to state-of-the-art facilities, the Trust is dedicated to fostering collaboration and ensuring the highest ethical standards in clinical research, ultimately contributing to the development of new treatments and therapies for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leeds, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials